Manufacturing company Leggett & Platt (NYSE:LEG) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.8% year on year to $1.02 billion. On the other hand, the company’s full-year revenue guidance of $4.15 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.24 per share was 9.5% above analysts’ consensus estimates.
The relationship between the US. Dollar Index, stock markets, and commodity prices during periods of trade tension follows distinct patterns that experienced investors can leverage for strategic positioning.
Chip manufacturer NXP Semiconductors (NASDAQ: NXPI) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 9.3% year on year to $2.84 billion. The company expects next quarter’s revenue to be around $2.9 billion, close to analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.4% above analysts’ consensus estimates.
Network application delivery and security specialist F5 (NASDAQ:FFIV) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.3% year on year to $731.1 million. The company expects next quarter’s revenue to be around $750 million, close to analysts’ estimates. Its non-GAAP profit of $3.42 per share was 10.2% above analysts’ consensus estimates.
Wellness company Medifast (NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million underwhelmed, coming in 15.4% below analysts’ estimates. Its GAAP loss of $0.07 per share was 72% above analysts’ consensus estimates.
